217 related articles for article (PubMed ID: 32011151)
21. Improving Correlations Between Drug Solubilization and In Vitro Lipolysis by Monitoring the Phase Partitioning of Lipolytic Species for Lipid-Based Formulations.
Dening TJ; Joyce P; Prestidge CA
J Pharm Sci; 2019 Jan; 108(1):295-304. PubMed ID: 30257194
[TBL] [Abstract][Full Text] [Related]
22. Five-Stage Approach for a Systematic Screening and Development of Etravirine Amorphous Solid Dispersions by Hot-Melt Extrusion.
Simões MF; Pereira A; Cardoso S; Cadonau S; Werner K; Pinto RMA; Simões S
Mol Pharm; 2020 Feb; 17(2):554-568. PubMed ID: 31774685
[TBL] [Abstract][Full Text] [Related]
23. Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine.
Porter CJ; Kaukonen AM; Taillardat-Bertschinger A; Boyd BJ; O'Connor JM; Edwards GA; Charman WN
J Pharm Sci; 2004 May; 93(5):1110-21. PubMed ID: 15067688
[TBL] [Abstract][Full Text] [Related]
24. Nanostructured lipid carriers versus microemulsions for delivery of the poorly water-soluble drug luteolin.
Liu Y; Wang L; Zhao Y; He M; Zhang X; Niu M; Feng N
Int J Pharm; 2014 Dec; 476(1-2):169-77. PubMed ID: 25280882
[TBL] [Abstract][Full Text] [Related]
25. Impact of Drug Physicochemical Properties on Lipolysis-Triggered Drug Supersaturation and Precipitation from Lipid-Based Formulations.
Alskär LC; Keemink J; Johannesson J; Porter CJH; Bergström CAS
Mol Pharm; 2018 Oct; 15(10):4733-4744. PubMed ID: 30142268
[TBL] [Abstract][Full Text] [Related]
26. Structural development of self nano emulsifying drug delivery systems (SNEDDS) during in vitro lipid digestion monitored by small-angle X-ray scattering.
Fatouros DG; Deen GR; Arleth L; Bergenstahl B; Nielsen FS; Pedersen JS; Mullertz A
Pharm Res; 2007 Oct; 24(10):1844-53. PubMed ID: 17458683
[TBL] [Abstract][Full Text] [Related]
27. How relevant are assembled equilibrium samples in understanding structure formation during lipid digestion?
Phan S; Salentinig S; Hawley A; Boyd BJ
Eur J Pharm Biopharm; 2015 Oct; 96():117-24. PubMed ID: 26212786
[TBL] [Abstract][Full Text] [Related]
28. A closer look at the behaviour of milk lipids during digestion.
Clulow AJ; Salim M; Hawley A; Boyd BJ
Chem Phys Lipids; 2018 Mar; 211():107-116. PubMed ID: 29100945
[TBL] [Abstract][Full Text] [Related]
29. Effect of lipids on absorption of carvedilol in dogs: Is coadministration of lipids as efficient as a lipid-based formulation?
Alskär LC; Parrow A; Keemink J; Johansson P; Abrahamsson B; Bergström CAS
J Control Release; 2019 Jun; 304():90-100. PubMed ID: 31047962
[TBL] [Abstract][Full Text] [Related]
30. Drug solubilization behavior during in vitro digestion of simple triglyceride lipid solution formulations.
Kaukonen AM; Boyd BJ; Porter CJ; Charman WN
Pharm Res; 2004 Feb; 21(2):245-53. PubMed ID: 15032305
[TBL] [Abstract][Full Text] [Related]
31. Probing Pharmaceutical Mixtures during Milling: The Potency of Low-Frequency Raman Spectroscopy in Identifying Disorder.
Walker G; Römann P; Poller B; Löbmann K; Grohganz H; Rooney JS; Huff GS; Smith GPS; Rades T; Gordon KC; Strachan CJ; Fraser-Miller SJ
Mol Pharm; 2017 Dec; 14(12):4675-4684. PubMed ID: 29091447
[TBL] [Abstract][Full Text] [Related]
32. Computational Models of the Gastrointestinal Environment. 2. Phase Behavior and Drug Solubilization Capacity of a Type I Lipid-Based Drug Formulation after Digestion.
Birru WA; Warren DB; Han S; Benameur H; Porter CJ; Pouton CW; Chalmers DK
Mol Pharm; 2017 Mar; 14(3):580-592. PubMed ID: 27936778
[TBL] [Abstract][Full Text] [Related]
33. Addition of Cationic Surfactants to Lipid-Based Formulations of Poorly Water-Soluble Acidic Drugs Alters the Phase Distribution and the Solid-State Form of the Precipitate Upon In Vitro Lipolysis.
Khan J; Rades T; Boyd BJ
J Pharm Sci; 2018 Sep; 107(9):2420-2427. PubMed ID: 29859958
[TBL] [Abstract][Full Text] [Related]
34. Montmorillonite and Laponite Clay Materials for the Solidification of Lipid-Based Formulations for the Basic Drug Blonanserin: In Vitro and in Vivo Investigations.
Dening TJ; Thomas N; Rao S; van Looveren C; Cuyckens F; Holm R; Prestidge CA
Mol Pharm; 2018 Sep; 15(9):4148-4160. PubMed ID: 30067372
[TBL] [Abstract][Full Text] [Related]
35. Real time Raman imaging to understand dissolution performance of amorphous solid dispersions.
Tres F; Treacher K; Booth J; Hughes LP; Wren SA; Aylott JW; Burley JC
J Control Release; 2014 Aug; 188():53-60. PubMed ID: 24910191
[TBL] [Abstract][Full Text] [Related]
36. Rapid determination of drug solubilization versus supersaturation in natural and digested lipids.
Gautschi N; Bergström CA; Kuentz M
Int J Pharm; 2016 Nov; 513(1-2):164-174. PubMed ID: 27609663
[TBL] [Abstract][Full Text] [Related]
37. Study of drug supersaturation for rational early formulation screening of surfactant/co-solvent drug delivery systems.
Stillhart C; Cavegn M; Kuentz M
J Pharm Pharmacol; 2013 Feb; 65(2):181-92. PubMed ID: 23278685
[TBL] [Abstract][Full Text] [Related]
38. Impact of gastrointestinal lipolysis on oral lipid-based formulations and bioavailability of lipophilic drugs.
Carrière F
Biochimie; 2016 Jun; 125():297-305. PubMed ID: 26607242
[TBL] [Abstract][Full Text] [Related]
39. Ionic Liquid Forms of Weakly Acidic Drugs in Oral Lipid Formulations: Preparation, Characterization, in Vitro Digestion, and in Vivo Absorption Studies.
Sahbaz Y; Nguyen TH; Ford L; McEvoy CL; Williams HD; Scammells PJ; Porter CJH
Mol Pharm; 2017 Nov; 14(11):3669-3683. PubMed ID: 28954512
[TBL] [Abstract][Full Text] [Related]
40. Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water-soluble drugs II. In-vivo evaluation.
Nguyen TH; Hanley T; Porter CJ; Larson I; Boyd BJ
J Pharm Pharmacol; 2010 Jul; 62(7):856-65. PubMed ID: 20636873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
